Evidence map›Paper›PMID 41381426›Full record

ArticleNature communications2025

Structures of human glucose-6-phosphate transporter reveal reciprocal antiport mechanism driving glucose-6-phosphate and inorganic phosphate exchange.

Qian Wang, Ningjie Guo, Yunxiang Du, Junwu Liu, Wanting Ai, Fengyi Yang, Yuanzai Zhu, Yuanyuan Zhao, Di Wu, Lei Liu and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qian Wang *Department of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.ORCID http://orcid.org/0009-0001-5215-4533
Ningjie Guo *Department of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Yunxiang Du *New Cornerstone Science Laboratory, Tsinghua-Peking Joint Center for Life Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Center for Synthetic and Systems Biology, Department of Chemistry, Tsinghua University, Beijing, China.ORCID http://orcid.org/0000-0003-3061-724X
Junwu Liu *Department of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.ORCID http://orcid.org/0009-0005-6944-1319
Wanting AiDepartment of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Fengyi YangDepartment of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Yuanzai ZhuDepartment of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Yuanyuan ZhaoDepartment of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Di WuDepartment of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.ORCID http://orcid.org/0000-0001-9748-4408
Lei LiuNew Cornerstone Science Laboratory, Tsinghua-Peking Joint Center for Life Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Center for Synthetic and Systems Biology, Department of Chemistry, Tsinghua University, Beijing, China. lliu@tsinghua.edu.cn.
Xia YaoDepartment of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China. xia_yao@whu.edu.cn.ORCID http://orcid.org/0000-0003-2406-268X
Shuai GaoDepartment of Urology, Zhongnan Hospital of Wuhan University, State Key Laboratory of Metabolism and Regulation in Complex Organisms, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China. gaoshuai812@whu.edu.cn.ORCID http://orcid.org/0000-0002-8734-2489

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22477098
6 · The paper itself

Abstract

Glucose-6-phosphate transporter 1 (G6PT1) is essential for systemic glucose homeostasis, and its deficiency causes glycogen storage disease type 1b (GSD1b). G6PT1 functions as a sugar-phosphate/inorganic phosphate (Pi) antiporter, orchestrating G6P transport into the endoplasmic reticulum lumen driven by a Pi gradient. Despite its physiological significance, the molecular mechanisms underlying substrate recognition and antiport activity remain poorly characterized. Here, we present cryo-electron microscopy structures of human G6PT1 in apo, Pi-bound, and GlcN6P-bound (a G6P analogue) states, all captured in cytosol-open conformations. Combined with molecular docking and functional assays, these structures elucidate the molecular basis for Pi and G6P recognition in G6PT1. Comparative analysis reveals that Pi binding triggers an interdomain salt bridge formation, resulting in a thicker luminal gate and a more compact central cavity for G6P binding. In addition to the monomer, we identify a dimeric assembly of G6PT1. Mutating key residues at the dimer interface impairs transport activity, suggesting a regulatory role for oligomerization. Our findings thus provide a mechanistic framework for understanding G6PT1 working mechanism and its pathological dysregulation in GSD1b.

Indexed as

Glucose-6-PhosphateMonosaccharide Transport ProteinsPhosphatesAntiportersCryoelectron MicroscopyGlycogen Storage Disease Type IHEK293 CellsHumansMolecular Docking SimulationProtein BindingProtein MultimerizationAntiportersGlucose-6-Phosphateglucose 6-phosphate(transporter)Monosaccharide Transport ProteinsPhosphates

Identifiers

PMID41381426
PMCPMC12748760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.